Abstract
Background: Invasive micropapillary carcinoma (IMPC) is a variant of breast carcinoma with a higher propensity for lymph node metastases compared with invasive ductal carcinoma (IDC).Methods:Retrospective analysis of 636 IMPC and 297 735 IDC cases in the Surveillance, Epidemiology and End Results database comparing disease-specific survival (DSS) and overall survival (OS) between IMPC and IDC.Results:A higher percentage of IMPC cases (52.0%) had nodal metastases compared with IDC cases (34.6%). The 5-year DSS and OS for IMPC was 91.8% and 82.9%, respectively compared with 88.6% and 80.5% for IDC, respectively. For both IMPC and IDC, oestrogen-receptor positivity was associated with better survival, while having four or more positive lymph nodes or larger tumour size correlated with worse survival. Radiotherapy provided a survival benefit for both histological types.Conclusions:Despite IMPC's higher propensity for lymph node metastasis, IMPC has DSS and OS that compare favourably with IDC. © 2014 Cancer Research UK. All rights reserved.
Cite
CITATION STYLE
Chen, A. C., Paulino, A. C., Schwartz, M. R., Rodriguez, A. A., Bass, B. L., Chang, J. C., & Teh, B. S. (2014). Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast. British Journal of Cancer, 111(3), 619–622. https://doi.org/10.1038/bjc.2014.301
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.